19 members / 773 guests (24 hours)

News on IDB Funding -- this is now on it's own page to clean up the site a bit.

In response to Re: MNKD secondary at $6 by r4r4 (10/11/2017, 4:17pm)

Re: MNKD secondary at $6

So true as they talked about a secondary at $2, so $6 is a home run. Big Pharma hates this stock and so do the hedge funds, so its so heavily shorted they want to win badly. All MNKD needs is 5% of a $40 billion a year market to be a grand slam. They will do whatever it takes to destroy this company and they haven't thrown in the towel yet. Love the new CEO and think he will deliver. Right now to borrow shares to short is at 99% interest, but they naked short the thing to death and the SEC turns a blind eye. 

RepliesTypeAuthorRecsPost DatePost
GNeasy010/11/2017, 6:58pm